Vulnerable plaque paradigm: Prediction of future clinical events based on a morphological definition

Catheterization and Cardiovascular Interventions

Volumn 62, Issue 3, 2004, Pages 364-374

  Granada, Juan F ^a,d   Kaluza, Grzegorz L ^a   Raizner, Albert E ^a   Moreno, Pedro R ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Mount Sinai University   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; AORTA ATHEROSCLEROSIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY THROMBOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; REVIEW;

ANIMALS; CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; DISEASE PROGRESSION; HUMANS;

EID: 3042700955     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20059     Document Type: Review

References (130)

1. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
2. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002;106:804-808.
3. Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-1485.
4. Maseri A, Fuster V. Is there a vulnerable plaque? Circulation 2003;107:2068-2071.
5. Paterson JC. Capillary rupture with intimal hemorrhage as a causative factor in coronary thrombosis. AMA Arch Pathol 1938;25:474-487.
6. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res 1966;6:1-17.
7. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-1322.
8. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 2003;107:2072-2075.
9. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310:1137-1140.
10. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-373.
11. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990;82:1138-1146.
12. Davies MJ. Anatomic features in victims of sudden coronary death: coronary artery pathology. Circulation 1992;85:119-124.
13. Davies MJ. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb Res 1996;82: 1-32.
14. Davies MJ. Pathology of coronary atherosclerosis. In: Fuster V, Alexander RW, O'Rourke RA, Roberts R, King SB III, Wellens HJJ, editors. Hurst's the heart. New York: McGraw-Hill; 2001. p 1095-1108.
15. Liberthson RR, Nagel EL, Hirschman JC, et al. Pathophysiologic observations in prehospital ventricular fibrillation and sudden cardiac death. Circulation 1974;49:790-798.
16. Davies MJ, Fulton WF, Robertson WB. The relation of coronary thrombosis to ischaemic myocardial necrosis. J Pathol 1979;127: 99-110.
17. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-134.
18. Falk E, Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995;75:3B-11B.
19. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93: 1354-1363.
20. van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89:36-44.
21. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671.
22. Farb A, Tang AL, Burke AP, et al. Sudden coronary death: frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 1995;92:1701-1709.
23. Wilcox JN, Smith KM, Schwartz SM, et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. 1989;86:2839-2843.
24. Femandez-Ortiz A, Badimon JJ, Falk E, et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994;23:1562-1569.
25. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 1996;94:3090-3097.
26. Toschi V, Gallo R, Lettino M, et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997;95:594-599.
27. Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001;89:1092-1103.
28. Horton DB, Libby P, Schonbeck U. Ligation of CD40 onvascular smooth muscle cells mediates loss of interstitial collagen via matrix metalloproteinase activity. Ann NY Acad Sci 2001;947: 329-336.
29. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-372.
30. Ambrose JA, Winters SL, Arora RR, et al. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 1985;6:1233-1238.
31. Ambrose JA, Winters SL, Stern A, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985;5:609-616.
32. Ambrose JA, Winters SL, Arora RR, et al. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol 1986;7:472-478.
33. Nakagawa S, Hanada Y, Koiwaya Y, et al. Angiographic features in the infarct-related artery after intracoronary urokinase followed by prolonged anticoagulation: role of ruptured atheromatous plaque and adherent thrombus in acute myocardial infarction in vivo. Circulation 1988;78:1335-1344.
34. Ambrose JA. Coronary arteriographic analysis and angiographic morphology. J Am Coll Cardiol 1989;13:1492-1494.
35. Haft JI, al Zarka AM. Comparison of the natural history of irregular and smooth coronary lesions: insights into the pathogenesis, progression, and prognosis of coronary atherosclerosis. Am Heart J 1993;126:551-561.
36. Levin DC, Fallon JT. Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations. Circulation 1982;66:316-320.
37. Chester MR, Chen L, Tousoulis D, et al. Differential progression of complex and smooth stenoses within the same coronary tree in men with stable coronary artery disease. J Am Coll Cardiol 1995;25:837-842.
38. Chen L, Chester MR, Redwood S, et al. Angiographic stenosis progression and coronary events in patients with "stabilized" unstable angina. Circulation 1995;91:2319-2324.
39. Kaski JC, Chester MR, Chen L, et al. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 1995; 92:2058-2065.
40. Chen L, Chester MR, Crook R, et al. Differential progression of complex culprit stenoses in patients with stable and unstable angina pectoris. J Am Coll Cardiol 1996;28:597-603.
41. Chester MR, Chen L, Kaski JC. The natural history of unheralded complex coronary plaques. J Am Coll Cardiol 1996;28: 604-608.
42. Guazzi MD, Bussotti M, Grancini L, et al. Evidence of multifocal activity of coronary disease in patients with acute myocardial infarction. Circulation 1997;96:1145-1151.
43. Kerensky RA, Wade M, Deedwania P, et al. Revisiting the culprit lesion in non-Q-wave myocardial infarction: results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 2002;39:1456-1463.
44. Corti R, Fuster V, Fayad ZA, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002;106:2884-2887.
45. den Heijer P, Foley DP, Hillege HL, et al. The "Ermenonville" classification of observations at coronary angioscopy: evaluation of intra- and inter-observer agreement-European Working Group on Coronary Angioscopy. Eur Heart J 1994;15:815-822.
46. Takano M, Mizuno K, Okamatsu K, et al. Mechanical and structural characteristics of vulnerable plaques: analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol 2001;38:99-104.
47. Thieme T, Wernecke KD, Meyer R, et al. Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol 1996;28:1-6.
48. Mizuno K, Miyamoto A, Satomura K, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1991;337:809-812.
49. Wagner WD, St Clair RW, Clarkson TB, et al. A study of atherosclerosis regression in Macaca mulatta: 3, chemical changes in arteries from animals with atherosclerosis induced for 19 months and regressed for 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl. Am J Pathol 1980;100:633-650.
50. Loree HM, Tobias BJ, Gibson LJ, et al. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler Thromb 1994;14:230-234.
51. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-1282.
52. Loree HM, Kamm RD, Stringfellow RG, et al. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992;71:850-858.
53. Lee RT, Schoen FJ, Loree HM, et al. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis: implications for plaque rupture. Arterioscler Thromb Vasc Biol 1996;16:1070-1073.
54. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503.
55. Fuster V. Lewis A. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90:2126-2146.
56. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001;89:305-316.
57. Hodgson JM, Graham SP, Savakus AD, et al. Clinical percutaneous imaging of coronary anatomy using an over-the-wire ultrasound catheter system. Int J Cardiol Imaging 1989;4:187-193.
58. Nissen SE, Gurley JC. Application of intravascular ultrasound for detection and quantitation of coronary atherosclerosis. Int J Cardiol Imaging 1991;6:165-177.
59. Yock PG, Fitzgerald PJ. Intravascular ultrasound: state of the art and future directions. Am J Cardiol 1998;81:27E-32E.
60. Nissen SE, Gurley JC, Grines CL, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991; 84:1087-1099.
61. Hermiller JB, Tenaglia AN, Kisslo KB, et al. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 1993;71:665-668.
62. Schoenhagen P, Ziada KM, Kapadia SR, et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000; 101:598-603.
63. Ge J, Chirillo F, Schwedtmann J, et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart 1999;81:621-627.
64. Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000;35:106-111.
65. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001;103:604-616.
66. Peters RJ, Kok WE, Havenith MG, et al. Histopathologic validation of intracoronary ultrasound imaging. J Am Soc Echocardiogr 1994;7:230-241.
67. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-1181.
68. Patwari P, Weissman NJ, Boppart SA, et al. Assessment of coronary plaque with optical coherence tomography and high-frequency ultrasound. Am J Cardiol 2000;85:641-644.
69. Fujimoto JG, Boppart SA, Tearney GJ, et al. High resolution in vivo intra-arterial imaging with optical coherence tomography. Heart 1999;82:128-133.
70. Brezinski ME, Tearney GJ, Weissman NJ, et al. Assessing atherosclerotic plaque morphology: comparison of optical coherence tomography and high frequency intravascular ultrasound. Heart 1997;77:397-403.
71. Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-609.
72. Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003;107:113-119.
73. Ledru F, Theroux P, Lesperance J, et al. Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction: a quantitative angiographic study. J Am Coll Cardiol 1999;33:1353-1361.
74. Lee RT, Loree HM, Cheng GC, et al. Computational structural analysis based on intravascular ultrasound imaging before in vitro angioplasty: prediction of plaque fracture locations. J Am Coll Cardiol 1993;21:777-782.
75. Cheng GC, Loree HM, Kamm RD, et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation 1993;87:1179-1187.
76. Ophir J, Cespedes I, Ponnekanti H, et al. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 1991;13:111-134.
77. de Korte CL, Sierevogel MJ, Mastik F, et al. Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation 2002;105: 1627-1630.
78. de Korte CL, Pasterkamp G, van der Steen AF, et al. Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro. Circulation 2000;102:617-623.
79. de Korte CL, van der Steen AF, Cespedes EI, et al. Intravascular ultrasound elastography in human arteries: initial experience in vitro. Ultrasound Med Biol 1998;24:401-408.
80. de Korte CL, Carlier SG, Mastik F, et al. Morphological and mechanical information of coronary arteries obtained with intravascular elastography: feasibility study in vivo. Eur Heart J 2002;23:405-413.
81. Romer TJ, Brennan JF III, Puppels GJ, et al. Intravascular ultrasound combined with Raman spectroscopy to localize and quantify cholesterol and calcium salts in atherosclerotic coronary arteries. Arterioscler Thromb Vasc Biol 2000;20:478-483.
82. Buschman HP, Marple ET, Wach ML, et al. In vivo determination of the molecular composition of artery wall by intravascular Raman spectroscopy. Anal Chem 2000;72:3771-3775.
83. Wang J, Geng YJ, Guo B, et al. Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques. J Am Coll Cardiol 2002;39:1305-1313.
84. Moreno PR, Lodder RA, Purushothaman KR, et al. Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation 2002;105:923-927.
85. Davies MJ. Glagovian remodelling, plaque composition, and stenosis generation. Heart 2000;84:461-462.
86. Moreno PR, Purushothaman KR, Fuster V, et al. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation 2002;105:2504-2511.
87. Hayden MR, Tyagi SC. Arteriogenesis: angiogenesis within unstable atherosclerotic plaque-interactions with extracellular matrix. Curr Interv Cardiol Rep 2000;2:218-227,
88. Purushothaman KR, Fuster V, O'Connor WN, Moreno PR. Neovascularization is the most powerful independent predictor for progression to disruption in high-risk atherosclerotic plaques. J Am Coll Cardiol 2003;41(Suppi A):352A.
89. Helft G, Worthley SG, Fuster V, et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation 2002;105:993-998.
90. Moreno PR, Purushothaman KR, Fuster V, O'Connor WN. Lipid core reduction is associated with decreased neovascularization in fibro-calcific atherosclerosis: implications for plaque regression. Circulation 2002;106(Suppl 2):11703.
91. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation 1994;89:503-505.
92. Moreno PR, Murcia AM, Palacios IF, et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000;102:2180-2184.
93. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993; 69:377-381.
94. Casscells W, Hathorn B, David M, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis, Lancet 1996;347: 1447-1451.
95. Verheye S, De Meyer GR, Van Langenhove G, et al. In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition. Circulation 2002;105:1596-1601.
96. Stefanadis C, Toutouzas P. In vivo local thermography of coronary artery atherosclerotic plaques in humans. Ann Intern Med 1998;129:1079-1080.
97. Stefanadis C, Diamantopoulos L, Dernellis J, et al. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J Mol Cell Cardiol 2000;32:43-52.
98. Stefanadis C, Diamantopoulos L, Vlachopoulos C, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation 1999; 99:1965-1971.
99. Stefanadis C, Toutouzas K, Tsiamis E, et al. Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol 2001;37: 1277-1283.
100. Vallabhajosula S, Paidi M, Badimon JJ, et al. Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. J Nucl Med 1988;29:1237-1245.
101. Vallabhajosula S, Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med 1997;38: 1788-1796.
102. Loscalzo J, Rocco TP. Imaging arterial thrombi: an elusive goal. Circulation 1992;85:382-385.
103. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications-a statement for health professionals from the American Heart Association Writing Group. Circulation 1996;94:1175-1192.
104. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000;101:850-855.
105. O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 2000;36:326-340.
106. Skinner MP, Yuan C, Mitsumori L, et al. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med 1995; 1:69-73.
107. Lin W, Abendschein DR, Haacke EM. Contrast-enhanced magnetic resonance angiography of carotid arterial wall in pigs. J Magn Reson Imaging 1997;7:183-190.
108. Toussaint JF, LaMuraglia GM, Southern JF, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94:932-938.
109. Fayad ZA, Nahar T, Fallon JT, et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation 2000;101:2503-2509.
110. Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102:506-510.
111. Zimmermann-Paul GG, Quick HH, Vogt P, et al. High-resolution intravascular magnetic resonance imaging: monitoring of plaque formation in heritable hyperlipidemic rabbits. Circulation 1999; 99:1054-1061.
112. Burke AP, Tracy RP, Kolodgie F, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002;105: 2019-2023.
113. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-2011.
114. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733.
115. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-1818.
116. Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000;101:1372-1378.
117. Heeschen C, Dimmeler S, Hamm CW, et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003;107:2109-2114.
118. Blankenberg S, Rupprecht HJ, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003;107:1579-1585.
119. Thorpe PE, Hunter WJ III, Zhan XX, et al. A noninjury, diet-induced swine model of atherosclerosis for cardiovascular-interventional research. Angiology 1996;47:849-857.
120. Gerrity RG, Natarajan R, Nadler JL, et al. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001;50:1654-1665.
121. Badimon L. Atherosclerosis and thrombosis: lessons from animal models. Thromb Haemost 2001;86:356-365.
122. Keelan P, Bayes-Genis A, Kantor B, Singh R, Carlson P, Lewis D, Schwartz RS. A novel porcine model for in vivo detection of vulnerable plaque: deposition and localization of lipid-rich lesions in the coronary arterial wall. Circulation 2001;17:67.
123. Granada JF., Moreno PR, Raizner AE, et al. Complex atherosclerotic lesions identifiable by IVUS in porcine coronary arteries induced by percutaneous local delivery of lipids into the vessel wall: preliminary results on the development of a vulnerable plaque model. Am J Cardiol 2003;92(Suppl 6A):222L.
124. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000;343:915-922.
125. Meier B, Ramamurthy S. Plaque sealing by coronary angioplasty. Cathet Cardiovasc Diagn 1995;36:295-297.
126. Moreno PR, Kilpatrick D, Purushothaman KR, Coleman L, O'Connor WN. Stenting vulnerable plaques improves plaque thickness and reduces lipid content: understanding alternatives for plaque stabilization. Am J Cardiol 2002;90(Suppl H):50H.
127. Moreno PR. Mechanical approaches to vulnerable plaque: treatment of nonhemodynamically significant "vulnerable" lesions with drug-eluting and noneluting stents: pathologic insights and clinical speculations. 2003; www.tctmd.com/expert-presentations/multi-slide.html?product_id=4086.
128. Chou TM, Woodburn KW, Cheong WF, et al. Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium. Catheter Cardiovasc Interv 2002;57:387-394.
129. Mazur W, Ali MN, Khan MM, et al. High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses. Int J Radiat Oncol Biol Phys 1996;36:777-788.
130. Fitzgerald PJ, Takagi A, Moore MP, et al. Intravascular sonotherapy decreases neointimal hyperplasia after stent implantation in swine. Circulation 2001;103:1828-1831.